Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by SanFrancisco99on May 07, 2014 4:35pm
272 Views
Post# 22535535

RE:RE:RVX - EVENTS/WEBCASTS section updated...

RE:RE:RVX - EVENTS/WEBCASTS section updated...ToInv:  Thank you again for your post.  One particularly interesting part of your post to me is about the office recombination.

My question is this:  Do you think the office sharing is a prelude to an organizational re-combo of the two firms?  I think that that is possible, but honestly I had not thought of that before and I am a little doubtful unless they have a suitor in mind who wants both sides of the equation (but in that case I think they would just sell the two halfs to the same company and hence recombine them that way).

And I'm wondering why they would have done the asset shuffle in March 2014 if they had plans to recombine the two companies....

Thus, I think the office sharing is just an office sharing... and not a recombo of the two entities.

I think that if a buyer wants both halves, then the recombo will automatcally happen when both are bought.  

If there are (or will be) two buyers, then no recombo is necessary....

Hence, I'm still thinking it is just an office sharing.

Just my two cents.  Not sayin' I'm right!




Bullboard Posts